关于酒精使用障碍的新型教育视频模块增加了治疗率并减少了回归酒精使用的可能性
Patrick Twohig1, Zachary P Slocum2, Anna Willet3
1Department of Gastroenterology and Hepatology, University of Rochester Medical Center, Rochester, NY 14682, United States. patrick_twohig@urmc.rochester.edu.
World journal of hepatology
|November 3, 2025
概括
一个教育视频模块 (EVM) 显著增加了酒精使用障碍 (AUD) 治疗率,并减少了住院患者的酒精复发. 这项干预措施解决了知识差距,改善了与酒精有关的肝病的护理.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 成 药物 药物 药物 药物
- 医学教育 医学教育
背景情况:
- 患者和医疗保健提供者往往缺乏对可用的酒精使用障碍 (AUD) 治疗选择和途径的认识.
- 这种知识差距阻碍了对AUD的及时和有效干预,导致其严重的健康负担.
研究的目的:
- 评估新型交互式教育视频模块 (EVM) 对提高AUD治疗率的影响.
- 评估EVM在促进酒精相关性肝病住院患者中药理学和心理社会治疗参与方面的有效性.
主要方法:
- 一项前性单中心队列研究比较了EVM实施前后的治疗率.
- 患有酒精相关性肝病的患者观看了交互式EVM.
- 治疗被定义为在出院后30天内接受药物或心理社会支持.
主要成果:
- 观看EVM显著增加了药理治疗率 (50%对22%,P=0.0008) 和心理治疗率 (73.8%对44%,P=0.01).
- EVM与回归酒精使用的显著减少有关 (7.9%与35.6%,P=0.003).
- 100%的参与者推使用 EVM.
结论:
- 教育视频模块提供了一种标准化的方法,用于教育住院患者关于AUD治疗.
- 这种干预可以弥合患者和医疗服务提供者的知识差距,可能减少与酒精有关的肝病的影响.
- 需要进一步的多中心研究来验证这些发现在更大的人群中.
相关概念视频
Substance Use Disorders Affecting Sleep
394
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
394
Drug Dependence
1.6K
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.6K
Treatment Strategies for Psychological Disorders
687
Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
687
Community Based Intervention
265
Community-based interventions in mental health represent a paradigm shift from institution-centered care to treatments embedded within the fabric of local communities. By prioritizing inclusion and leveraging existing societal structures, this approach fosters a supportive environment conducive to addressing mental health challenges while promoting individual dignity and agency.
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
265
Drug Abuse and Addiction: Pharmacological Phenomena
1.1K
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
1.1K
Alzheimer's Disease: Treatment
801
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
801


